A Number Every Morning: Understanding Heart Rate Variability Tracking in POTS and Hypermobility

If you have ever woken up, reached for your phone before your feet touched the floor, read a two-digit number, and let it decide whether today would be a good day or a careful one, you know how quickly a wearable starts running your morning.

Heart rate variability tracking has become a daily ritual for many people living with POTS, hypermobility or long COVID, and the research is clearer than most expect on one point and murkier on another. A 2019 meta-analysis pooled twenty studies comparing 717 people with POTS against 641 healthy volunteers. The POTS group did have measurably lower variability on one family of measures, and no significant difference on the other. The authors closed by calling for the studies that would show whether the measure can identify an individual. One has since been done, and it is thinner than you would hope.

The good news? Understanding what the number is made of takes most of its power away, and what is left is genuinely useful.

At Rooted Motion Physical Therapy, we believe you are owed the honest state of the evidence rather than a tidy story. Let us walk through what heart rate variability tracking measures, how far your device can be trusted, and where it fits alongside care that changes how you feel.

What Does Heart Rate Variability Tracking Actually Measure?

Your heart does not beat like a metronome. Even at a steady sixty beats a minute the gaps between beats are never identical, and heart rate variability measures how much they differ.

The variation is not random. It largely reflects how much your breathing is modulating your heart rate through the vagus nerve—the calming, recovery side of the autonomic nervous system. More variation generally means more of that signal.

What it does not measure is a balance between calm and stress. A 2026 guidelines paper on the rigor and reproducibility of heart rate variability is unusually blunt about this: the measure is not appropriate as a marker of sympathetic outflow or of “sympathovagal balance,” and the low-to-high frequency ratio that many apps display should not be read that way. A low number does not mean you are in fight-or-flight. It means there was less breathing-driven variation in your heart rate last night.

Two people with the same average heart rate can have very different beat-to-beat spacing.

Why Is Heart Rate Variability Lower in POTS and Hypermobility?

That 2019 meta-analysis found that after a tilt test, people with POTS had a higher heart rate, shorter gaps between beats and lower variability on time-based measures. The frequency-based measures, often labeled low and high frequency in an app, did not separate the groups at all.

Hypermobility belongs in this conversation for a straightforward reason. In one series of 362 young people with POTS, 22.7 percent had Ehlers-Danlos syndrome and 39.0 percent had hypermobility spectrum disorder—more than three in five. If you have one, questions about the other are reasonable rather than far-fetched.

There is early work in hypermobile Ehlers-Danlos syndrome specifically: a 2025 study of 26 people across 122 device-days found slow-moving components of variability differed on days with worse symptoms. The authors call it pilot data. Variability moves with a bad day. No study has yet shown it arriving before one.

Imagine Checking Your Bank Balance on One Morning

Open your banking app the day after payday and the balance looks excellent. Open it the day rent clears and it looks alarming. Neither tells you whether you can afford a holiday in March.

What answers it is the shape of the line across months, compared to your own line rather than somebody else's, and there are now numbers for how much a single reading moves on its own. In nine million measurements from free-living adults, heart rate variability fell about 12 percent after a heavy drinking night, about 10 percent during an illness, and shifted about 3 percent across the menstrual cycle. None of that is your condition changing.

How long does it take to see past that? An analysis of roughly two million nights from more than 21,000 wearable users found that at least five nights out of seven were needed before a week's worth of variability could be trusted at all. Not one morning. Five nights, minimum, and a week or two is safer.

The key idea: your heart rate variability number is a balance, not a budget. It takes at least five nights before a weekly figure means anything, and the trend against your own baseline is the part that carries information. One morning is mostly noise.

Why a Group Difference Is Not a Personal Test

When a study reports that a POTS group has lower variability than a control group, it is describing two clouds of people that overlap heavily. Plenty in the POTS group score higher than plenty in the control group. A difference between averages can be real and still be useless for deciding anything about one person.

Turning that into a personal test takes a different study—one reporting how often the measure correctly flags someone who has the condition, and how often it wrongly flags someone who does not. The 2019 meta-analysis ended by asking for exactly those studies. One has since been done: a 2026 analysis of Holter recordings from 19 adolescents with POTS and 44 healthy volunteers found its best index caught about 78 percent of the patients while correctly clearing about 89 percent of the controls.

That sounds encouraging until you look at who was being told apart. Nineteen patients is very small, the authors say the thresholds need validating elsewhere before anyone uses them, and the comparison was against healthy volunteers. Nobody struggles to tell a person with POTS from a healthy teenager. The hard question is separating POTS from deconditioning or anxiety, and that has not been tested. So a low reading is still not a diagnosis, and a normal one is still not a clean bill of health.

This is not a new caution here. The 2026 international expert consensus makes the parallel point about heart rate itself, noting that many people with real orthostatic intolerance and real impairment never meet the required threshold, and go undiagnosed as a result. Numbers sort people for research. They do not settle whether a person is unwell.

That consensus defines POTS on a sustained heart rate rise during a ten-minute standing or tilt protocol, not on anything a ring records overnight. And no overnight score can tell you whether you are safe to exercise today, or replace someone watching what happens across the twenty minutes after you stand up.

How Accurate Is the Device on Your Wrist or Finger?

Less uniformly than you would hope, and it depends on which one you own.

A 2025 validation study put five consumer devices against a reference electrocardiogram across 536 nights of sleep. For variability the Oura Generation 4 came closest, averaging just under 6 percent error, then the Oura Generation 3 at about 7 percent and the WHOOP 4.0 at about 8 percent. The Garmin Fenix 6 averaged around 10.5 percent, the Polar Grit X Pro around 16 percent.

Three cautions travel with those figures: thirteen healthy adults, so 536 is nights rather than people; sleep only; and nobody in it had a tachycardia or an autonomic condition, which is precisely who is reading this. If your device carries a 10 percent error and your reading moves 8 percent overnight, you may not have observed anything.

Daily readings against a rolling baseline. The scatter is normal; the drift is the signal.

Can Anything Actually Change It?

Honestly, less is known than the marketing implies, and the gap is specific. The large trials that established exercise as a treatment for POTS measured standing heart rate, blood volume and quality of life. They did not report heart rate variability as an outcome at all, so there is no established figure for how much a three-month program moves this number in this condition.

Breathing training has slightly better evidence, and it is still early. A 2025 phase II controlled trial in long COVID assigned people alternately to ten sessions of heart-rate-variability biofeedback or to usual care, and found significantly greater improvement in severe fatigue in the biofeedback group. The authors call it justification for a phase III trial, not proof—and it was not done in POTS.

What has better support for POTS symptoms, as opposed to for the number, is unglamorous. A 2019 National Institutes of Health consensus notes that up to 70 percent of people with POTS have a blood volume deficit and no medication is FDA-approved, which puts the weight on education, fluid and sodium strategies agreed with your physician, compression, and graded exercise. And the number should not become a target: a 2024 review found 220-minus-your-age likely neither realistic nor appropriate here.

So What Is Worth Tracking Instead?

If you enjoy the data, keep the device. Nothing here says throw it away—only that it should stay a habit rather than a verdict.

• Look at weeks, not mornings. A four-week trend against your own baseline says something a Tuesday does not.

• Track what you did, not only what you scored. Minutes upright and how the next day felt are more actionable than any index.

• Write down the crashes and what preceded them. Your own history is better evidence than a population average.

• Notice if the number has started making your decisions. A tool that talks you out of things you could have done is costing you more than it returns.

The Rooted Motion Difference

We provide one-on-one mobile care throughout Richmond, Henrico, Chesterfield and Midlothian. Where standing up is the hard part and the drive to a clinic costs you the appointment, being seen at home is what makes the assessment possible:

• An unhurried assessment in the room where your symptoms happen.

• Objective measures taken with you, in positions you tolerate, rather than inferred from an app.

• A graded plan that starts where you are and progresses on how you respond, not on a calendar.

• Honest separation of what the evidence supports from what is clinical judgement.

• Coordination with your physician, because fluid, sodium and medication decisions are theirs.

• Convenient concierge mobile physical therapy delivered where you are.

Because recovery is not about a better number in an app—it is about a longer, steadier day.

Ready to Stop Negotiating With a Number?

If your morning has started with a score and a small argument with yourself, an assessment of what you can actually do—in the place where you have to do it—is worth more than another week of data. You do not have to navigate this alone.

Schedule a one-on-one evaluation and we will build a plan around what your body tolerates and what your day requires.

Ready to move better and live rooted? Contact Rooted Motion Physical Therapy to schedule a one-on-one evaluation and begin a personalized plan built around the day you actually have to get through.

Research Used for This Article

1. Swai J, Hu Z, Zhao X, Rugambwa T, Ming G. Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis. BMC Cardiovascular Disorders. 2019;19(1):320. DOI

2. Carter JR, Jenkins NDM, Bigalke JA, et al. Guidelines for rigor and reproducibility of heart rate variability within human cardiovascular research. American Journal of Physiology-Heart and Circulatory Physiology. 2026;331(3):H918-H943. DOI

3. Kakavand B, Ebadi A, Kakavand AA, Rueda-De-Leon E. Holter-based heart rate variability distinguishes adolescent postural orthostatic tachycardia syndrome from healthy controls. Pediatric Cardiology. 2026. DOI

4. Sivakoti K, Cortez M, Fedorowski A, et al. Postural orthostatic tachycardia syndrome (POTS) and dysautonomia: international multidisciplinary expert consensus. American Journal of Medicine. 2026. DOI

5. Boris JR, Bernadzikowski T. Prevalence of joint hypermobility syndromes in pediatric postural orthostatic tachycardia syndrome. Autonomic Neuroscience. 2021;231:102770. DOI

6. Mathena SA, Allen RM, Laukaitis C, Andrews JG. Tracking changes in autonomic function by coupled analysis of wavelet-based dispersion of heart rate variability and gastrointestinal symptom severity in individuals with hypermobile Ehlers-Danlos syndrome. Frontiers in Neurology. 2025;15:1499582. DOI

7. Grosicki GJ, Carter JR, Laursen PB, et al. Heart rate variability coefficient of variation during sleep as a digital biomarker that reflects behavior and varies by age and sex. American Journal of Physiology-Heart and Circulatory Physiology. 2025;330(1):H187-H199. DOI

8. Altini M, Plews D. What is behind changes in resting heart rate and heart rate variability? A large-scale analysis of longitudinal measurements acquired in free-living. Sensors. 2021;21(23):7932. DOI

9. Dial MB, Hollander ME, Vatne EA, Emerson AM, Edwards NA, Hagen JA. Validation of nocturnal resting heart rate and heart rate variability in consumer wearables. Physiological Reports. 2025;13(16):e70527. DOI

10. Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Autonomic Neuroscience. 2021;235:102828. DOI

11. Cossu G, Kalcev G, Primavera D, et al. The use of heart rate variability-biofeedback (HRV-BF) as an adjunctive intervention in chronic fatigue syndrome (CFS/ME) in long COVID: results of a phase II controlled feasibility trial. Journal of Clinical Medicine. 2025;14(15):5363. DOI

12. Trimble KZ, Switzer JN, Blitshteyn S. Exercise in postural orthostatic tachycardia syndrome: focus on individualized exercise approach. Journal of Clinical Medicine. 2024;13(22):6747. DOI

Educational disclaimer: This article is for general education and is not a substitute for an individualized evaluation. No wearable reading should delay care. Seek prompt medical attention for fainting rather than near-fainting; chest pain; shortness of breath at rest; a racing heart that will not settle when lying down; or symptoms that begin abruptly.